Jackson Douglas, Botea Andrei, Gubenko Yuriy, Delphin Ellise, Bennett Henry
Department of Anesthesiology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07101, USA.
Anesth Analg. 2006 Mar;102(3):724-8. doi: 10.1213/01.ane.0000197779.03866.ad.
During orthotopic liver transplantation a patient received epsilon-aminocaproic acid and clotting factors. Shortly after hepatic artery clamping the patient developed a massive intracardiac/intravascular thrombosis that resulted in cardiac arrest. After diagnosis by transesophageal echocardiography, the patient was treated with recombinant tissue plasminogen activator through a central venous catheter advanced into the right atrium. After treatment with recombinant tissue plasminogen activator, the patient's hemodynamic status improved, permitting the liver transplant to be completed. The patient was ultimately discharged to home. We report the successful intraoperative resuscitation of a patient with acute intracardiac/intravascular thrombosis during an orthotopic liver transplantation using thrombolytic therapy.
在原位肝移植过程中,一名患者接受了ε-氨基己酸和凝血因子治疗。肝动脉夹闭后不久,患者出现大量心内/血管内血栓形成,导致心脏骤停。经食管超声心动图诊断后,通过插入右心房的中心静脉导管对患者进行重组组织型纤溶酶原激活剂治疗。使用重组组织型纤溶酶原激活剂治疗后,患者的血流动力学状态改善,使肝移植得以完成。患者最终出院回家。我们报告了一例在原位肝移植术中使用溶栓疗法成功复苏急性心内/血管内血栓形成患者的病例。